Send me a link:

*Text messaging rates may apply.

 Dow Down0.02% Nasdaq Down0.04%

Cytori Therapeutics, Inc. (CYTX)

-NasdaqGM
2.16 Down 0.04(1.82%) 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 12,196   14,501   9,996  
Cost of Revenue3,421  4,000  3,837  
Gross Profit 8,775   10,501   6,159  
Operating Expenses
Research Development17,065  13,628  10,904  
Selling General and Administrative22,389  25,291  24,667  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (30,679) (28,418) (29,412)
Income from Continuing Operations
Total Other Income/Expenses Net7,946  (310)(46)
Earnings Before Interest And Taxes(22,025)(28,728)(29,458)
Interest Expense3,396  3,386  2,784  
Income Before Tax(25,421)(32,114)(32,242)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(26,177)(32,279)(32,451)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (26,177) (32,279) (32,451)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (26,177) (32,279) (32,451)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.